ArticleBlood2011
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.
Sarah E M Herman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
441 papers cite itlatest 60 shown
this paperpooled ittrialcites it